Developer docs
API playgroundTry for free, no card

Search company profiles

Cayceo

Full company profile

uuid000r1dd

Namestring
Cayceo
Legal namestring
SAS CAYCEO
Websiteurl
cayceo.fr
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Cayceo (SAS CAYCEO) is a Montpellier-based French company that develops IPNEO, a Class 1 certified medical device combining immersive virtual reality software with a library of clinical-grade hypnotic sessions for non-pharmacological anxiety and pain management. The platform pairs custom VR environments (Le Bois aux lanternes, Au-delà du Lagon, La Galerie des glaces, La Tête dans les nuages) with a tactile control solution that allows a single caregiver to pilot one or multiple VR headsets. Sessions are co-developed internally by 3D artists applying video game and animation cinema techniques in conjunction with a multidisciplinary medical board anchored by clinical psychologist Jean-Michel Marty and Professor Antoine Bioy of Université Paris 8.

The company monetises IPNEO through direct institutional sales to French hospitals, university hospital centres (CHU), private clinics, and cancer institutes under a subscription or annual licensing model with no public pricing; quotes are provided on a consultative basis via a contact form. Distribution is dual-channel: direct institutional sales supplemented by listing on UGAP, the French public procurement agency, which allows public healthcare institutions to procure through official frameworks. The customer base includes major French CHUs (Bordeaux, Toulouse, Lyon, Nîmes, AP-HP Bicêtre and Necker), the ICM Unicancer cancer centre, and private groups such as Elsan Care and Clinique Bonnefon. The firm operates with a 1–10 person headcount from an atelier inside the Halle Tropisme innovation campus in Montpellier.

In 2023, Cayceo was acquired by Lumeen, a strategic acquirer in the therapeutic VR space, with the stated intent of building the most comprehensive therapeutic VR solution on the market. Following the acquisition, the Cayceo brand and product continue to operate as a portfolio entity under Lumeen, with clinical research partnerships and session-library expansion used both as validation mechanisms and as the primary commercial funnel within the French healthcare market.

Short descriptiontext

Cayceo develops IPNEO, a Class 1 certified medical VR device delivering immersive hypnotic sessions for non-pharmacological anxiety and pain management, sold to French hospitals, clinics, and cancer institutes.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical virtual reality, digital therapeutics devices, VR pain management, clinical hypnosis software, hospital anxiety treatment
Industry1 code
PRIMARYHLALAAAA
Primary Care & General Medicine Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Virtual Reality Therapy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1IPNEO Medical Device Licensing/Subscription
TypeSubscription Recurring
Description

IPNEO is sold as a Class 1 medical device combining VR software (hypnotic session library) and hardware piloting solution. Revenue is likely generated through device and software licensing, possibly subscription-based given the recurring nature of session updates and library evolution. The solution is offered to healthcare institutions ( CHU, clinics, cancer institutes) who purchase or lease the system for use across patient care pathways.

cayceo.fr
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Custom institutional pricing upon inquiry
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing tiers are listed. The company sells directly to healthcare institutions (hospitals, clinics, cancer institutes) via a contact form, indicating a consultative, quote-based sales model.

cayceo.fr
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1IPNEO
Description

First complete turnkey medical virtual reality hypnosis solution indicated for anxiety and pain management throughout the patient care pathway. Class 1 medical device combining VR software with hypnotic session library and tactile piloting hardware solution for single or multiple VR headsets.

cayceo.fr
Core offering1 text field

Cayceo develops and sells IPNEO, a Class 1 certified medical device combining VR software and a library of medically validated hypnotic sessions with a tactile piloting solution for single or multiple VR headsets. The system provides non-pharmacological anxiolytic and analgesic treatment for patients undergoing medical procedures, and is sold to hospitals, clinics, and cancer institutes across France.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 98% of healthcare professionals recommend the sessions (study of 50 professionals, CFHTB 2019)
+2 more records
Product overview1 text field

Cayceo offers IPNEO, a certified Class 1 medical device that is the first complete turnkey solution for medical hypnosis in virtual reality. The product combines VR software with a library of hypnotic sessions designed for specific clinical indications in anxiety and pain management. The portfolio includes four distinct session types: Le Bois aux lanternes (hypno-relaxation), Au-delà du Lagon (hypno-relaxation), La Galerie des glaces (hypnoanalgesia), and La tête dans les nuages (hypno-sedation), each adaptable in duration to match the care procedure rather than the reverse. The sessions are developed by 3D artists and clinical practitioners, with a multidisciplinary medical board overseeing the production. Cayceo was acquired by Lumeen with the goal of offering the most comprehensive therapeutic VR solution on the market.

Product and service1 record
1IPNEO
CategoryMedical Virtual Reality Device
Description

IPNEO is a Class 1 certified medical device combining VR software and a library of hypnotic sessions for anxiolytic and analgesic purposes. It includes a tactile piloting solution for single or multi-VR headset configurations, enabling a single caregiver to manage multiple patients simultaneously. The system provides non-pharmacological hypnosis therapy for patients managing anxiety and pain throughout their care journey, used by hospitals, clinics, and cancer institutes in France.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeOthersAnnounced on2022-01-01
Description

Cayceo was acquired by Lumeen, with the stated promise of offering the most comprehensive therapeutic VR solution on the market. Lumeen subsequently acquired Cayceo to expand its portfolio in therapeutic virtual reality, combining Cayceo's medical hypnosis VR expertise with Lumeen's broader VR offerings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

IPNOSIA is co-led by Pr Antoine Bioy (responsible scientist for IPNOSIA, Professor at Paris 8, UNESCO scientific advisor, and President of the 'Humanisation des soins' commission at Fondation de France). IPNOSIA provides scientific oversight and clinical validation for Cayceo's IPNEO sessions, contributing to the medical board that governs session development.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

UGAP (Union des Groupements d'Achats Publics) is the French public procurement agency. Cayceo's IPNEO solution is listed on UGAP, allowing French public healthcare institutions to purchase the solution through official government procurement frameworks.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Université Paris 8, where Pr Antoine Bioy serves as Professor, is listed as a trusted partner. The university connection provides academic and scientific credibility to Cayceo's IPNEO solution through the involvement of its faculty in the medical board.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Psious
TypeRegional player
Description

Spain-based VR platform for mental health professionals with similar anxiety-management use cases, primarily serving Iberian and Latin American markets.

TypeBroad incumbent
Description

Major VR hardware OEM exploring health and wellness applications. Competes indirectly by enabling third-party medical VR on consumer-grade headsets, lowering barriers for non-specialized alternatives.

3Oncomfort
TypeDirect peer
Description

Belgium-based medical VR for pain and anxiety management in hospitals. Comparable Class I/IIa certified digital therapeutic device with overlapping indications and European clinical focus.

TypeDirect peer
Description

US therapeutic VR platform FDA-authorized for chronic pain, with deployments across US health systems. Direct peer in VR-based non-pharmacological pain/anxiety therapy for clinical use.

TypeBroad incumbent
Description

Larger neuro/VR health platform with FDA/CE cleared products across rehab and cognition. Broad incumbent operating across multiple therapeutic VR verticals.

6XRHealth
TypeDirect peer
Description

VR therapy platform operating clinics and reimbursement-backed programs for pain, anxiety, and rehabilitation. Comparable model of clinically validated VR interventions sold to providers.

TypeDirect peer
Description

US therapeutic VR company building evidence-based VR programs for mental health, chronic pain, and oncology. Overlapping patient populations and clinical evidence-led positioning.

TypeDirect peer
Description

French medical hypnosis VR platform used for anesthesia, analgesia, and anxiety. Closest direct competitor — same therapeutic modality, same clinical use cases, and same French GTM motion.

TypeBroad incumbent
Description

Owns Quest VR headsets used in many healthcare VR pilots. Indirect but significant competitor via partnerships with hospital systems and third-party medical VR software developers.

TypeDirect peer
Description

Parent company and operator of a therapeutic VR platform for healthcare and eldercare. Directly comparable product category (therapeutic VR in care settings) and overlapping institutional customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cayceo

Medical Virtual Reality Therapycayceo.fr

Cayceo develops IPNEO, a Class 1 certified medical VR device delivering immersive hypnotic sessions for non-pharmacological anxiety and pain management, sold to French hospitals, clinics, and cancer institutes.

What Cayceo does

Cayceo (SAS CAYCEO) is a Montpellier-based French company that develops IPNEO, a Class 1 certified medical device combining immersive virtual reality software with a library of clinical-grade hypnotic sessions for non-pharmacological anxiety and pain management. The platform pairs custom VR environments (Le Bois aux lanternes, Au-delà du Lagon, La Galerie des glaces, La Tête dans les nuages) with a tactile control solution that allows a single caregiver to pilot one or multiple VR headsets. Sessions are co-developed internally by 3D artists applying video game and animation cinema techniques in conjunction with a multidisciplinary medical board anchored by clinical psychologist Jean-Michel Marty and Professor Antoine Bioy of Université Paris 8.

The company monetises IPNEO through direct institutional sales to French hospitals, university hospital centres (CHU), private clinics, and cancer institutes under a subscription or annual licensing model with no public pricing; quotes are provided on a consultative basis via a contact form. Distribution is dual-channel: direct institutional sales supplemented by listing on UGAP, the French public procurement agency, which allows public healthcare institutions to procure through official frameworks. The customer base includes major French CHUs (Bordeaux, Toulouse, Lyon, Nîmes, AP-HP Bicêtre and Necker), the ICM Unicancer cancer centre, and private groups such as Elsan Care and Clinique Bonnefon. The firm operates with a 1–10 person headcount from an atelier inside the Halle Tropisme innovation campus in Montpellier.

In 2023, Cayceo was acquired by Lumeen, a strategic acquirer in the therapeutic VR space, with the stated intent of building the most comprehensive therapeutic VR solution on the market. Following the acquisition, the Cayceo brand and product continue to operate as a portfolio entity under Lumeen, with clinical research partnerships and session-library expansion used both as validation mechanisms and as the primary commercial funnel within the French healthcare market.

Cayceo firmographics

Firmographics
Name
Cayceo
Legal name
SAS CAYCEO
Website
https://cayceo.fr
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
1–10 employees
Short description
Cayceo develops IPNEO, a Class 1 certified medical VR device delivering immersive hypnotic sessions for non-pharmacological anxiety and pain management, sold to French hospitals, clinics, and cancer institutes.
Ownership category
akta.pro rank

Cayceo industry classification

Industry
Product category
Medical Virtual Reality Therapy
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAAAA
Primary Care & General Medicine Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • Medical virtual reality
  • Digital therapeutics devices
  • VR pain management
  • Clinical hypnosis software
  • Hospital anxiety treatment

Where Cayceo is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Cayceo business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. IPNEO Medical Device Licensing/Subscription: IPNEO is sold as a Class 1 medical device combining VR software (hypnotic session library) and hardware piloting solution. Revenue is likely generated through device and software licensing, possibly subscription-based given the recurring nature of session updates and library evolution. The solution is offered to healthcare institutions ( CHU, clinics, cancer institutes) who purchase or lease the system for use across patient care pathways.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCustom institutional pricing upon inquiry

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Cayceo product offering

Product offering

Core offering

Cayceo develops and sells IPNEO, a Class 1 certified medical device combining VR software and a library of medically validated hypnotic sessions with a tactile piloting solution for single or multiple VR headsets. The system provides non-pharmacological anxiolytic and analgesic treatment for patients undergoing medical procedures, and is sold to hospitals, clinics, and cancer institutes across France.

Product overview

Cayceo offers IPNEO, a certified Class 1 medical device that is the first complete turnkey solution for medical hypnosis in virtual reality. The product combines VR software with a library of hypnotic sessions designed for specific clinical indications in anxiety and pain management. The portfolio includes four distinct session types: Le Bois aux lanternes (hypno-relaxation), Au-delà du Lagon (hypno-relaxation), La Galerie des glaces (hypnoanalgesia), and La tête dans les nuages (hypno-sedation), each adaptable in duration to match the care procedure rather than the reverse. The sessions are developed by 3D artists and clinical practitioners, with a multidisciplinary medical board overseeing the production. Cayceo was acquired by Lumeen with the goal of offering the most comprehensive therapeutic VR solution on the market.

Differentiator

Problem solved

Functional benefit

Brands

  • IPNEO: First complete turnkey medical virtual reality hypnosis solution indicated for anxiety and pain management throughout the patient care pathway. Class 1 medical device combining VR software with hypnotic session library and tactile piloting hardware solution for single or multiple VR headsets.

Products and services

  • IPNEO IPNEO is a Class 1 certified medical device combining VR software and a library of hypnotic sessions for anxiolytic and analgesic purposes. It includes a tactile piloting solution for single or multi-VR headset configurations, enabling a single caregiver to manage multiple patients simultaneously. The system provides non-pharmacological hypnosis therapy for patients managing anxiety and pain throughout their care journey, used by hospitals, clinics, and cancer institutes in France.

Quantifiable outcome

  • 98% of healthcare professionals recommend the sessions (study of 50 professionals, CFHTB 2019)
  • +2 more outcomes

Companies that use Cayceo

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles1 record

Cayceo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Cayceo partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • LumeencoreOthers · 1 January 2022Cayceo was acquired by Lumeen, with the stated promise of offering the most comprehensive therapeutic VR solution on the market. Lumeen subsequently acquired Cayceo to expand its portfolio in therapeutic virtual reality, combining Cayceo's medical hypnosis VR expertise with Lumeen's broader VR offerings.
  • IPNOSIA (Institut de Recherche en Hypnose Médicale)coreStrategic or Co-development Partner · 1 January 2019IPNOSIA is co-led by Pr Antoine Bioy (responsible scientist for IPNOSIA, Professor at Paris 8, UNESCO scientific advisor, and President of the 'Humanisation des soins' commission at Fondation de France). IPNOSIA provides scientific oversight and clinical validation for Cayceo's IPNEO sessions, contributing to the medical board that governs session development.
  • UGAPminorChannel Partner/ Reseller/ DistributorUGAP (Union des Groupements d'Achats Publics) is the French public procurement agency. Cayceo's IPNEO solution is listed on UGAP, allowing French public healthcare institutions to purchase the solution through official government procurement frameworks.
  • Université Paris 8 Vincennes-Saint-DenisminorStrategic or Co-development PartnerUniversité Paris 8, where Pr Antoine Bioy serves as Professor, is listed as a trusted partner. The university connection provides academic and scientific credibility to Cayceo's IPNEO solution through the involvement of its faculty in the medical board.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Cayceo competitors and assessment

Company assessment

Regional players

  • Psious: Spain-based VR platform for mental health professionals with similar anxiety-management use cases, primarily serving Iberian and Latin American markets.

Broad incumbents

  • Samsung Health (Samsung Electronics): Major VR hardware OEM exploring health and wellness applications. Competes indirectly by enabling third-party medical VR on consumer-grade headsets, lowering barriers for non-specialized alternatives.
  • MindMaze: Larger neuro/VR health platform with FDA/CE cleared products across rehab and cognition. Broad incumbent operating across multiple therapeutic VR verticals.
  • Meta (Reality Labs Health): Owns Quest VR headsets used in many healthcare VR pilots. Indirect but significant competitor via partnerships with hospital systems and third-party medical VR software developers.

Direct peers

  • Oncomfort: Belgium-based medical VR for pain and anxiety management in hospitals. Comparable Class I/IIa certified digital therapeutic device with overlapping indications and European clinical focus.
  • AppliedVR: US therapeutic VR platform FDA-authorized for chronic pain, with deployments across US health systems. Direct peer in VR-based non-pharmacological pain/anxiety therapy for clinical use.
  • XRHealth: VR therapy platform operating clinics and reimbursement-backed programs for pain, anxiety, and rehabilitation. Comparable model of clinically validated VR interventions sold to providers.
  • BehaVR: US therapeutic VR company building evidence-based VR programs for mental health, chronic pain, and oncology. Overlapping patient populations and clinical evidence-led positioning.
  • HypnoVR: French medical hypnosis VR platform used for anesthesia, analgesia, and anxiety. Closest direct competitor — same therapeutic modality, same clinical use cases, and same French GTM motion.
  • Lumeen: Parent company and operator of a therapeutic VR platform for healthcare and eldercare. Directly comparable product category (therapeutic VR in care settings) and overlapping institutional customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Cayceo social profiles

Digital presence

Cayceo compliance and trust

Trust signal

Compliance1 record

Cayceo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cayceo leadership team

Management profile

Number of profiles

Profiles1 record

Cayceo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cayceo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cayceo

What does Cayceo do?

Cayceo develops and sells IPNEO, a Class 1 certified medical device combining VR software and a library of medically validated hypnotic sessions with a tactile piloting solution for single or multiple VR headsets. The system provides non-pharmacological anxiolytic and analgesic treatment for patients undergoing medical procedures, and is sold to hospitals, clinics, and cancer institutes across France.

Is Cayceo a public or private company?

Cayceo is a private company. It is classified as corporate owned and is currently acquired.

When was Cayceo founded?

Cayceo was founded in 2017. It employs 1 to 10 people.

Where is Cayceo based?

Cayceo is headquartered in Montpellier, France, in the Europe region.

How does Cayceo make money?

One revenue line is on record: IPNEO Medical Device Licensing/Subscription.

Who are Cayceo's main competitors?

Psious is listed as a regional player. Broad incumbents are Samsung Health (Samsung Electronics), MindMaze and Meta (Reality Labs Health). Direct peers are Oncomfort, AppliedVR, XRHealth, BehaVR, HypnoVR and Lumeen.

Does Cayceo have an API?

No public API is recorded for Cayceo.

What industry is Cayceo in?

Cayceo's product category is Medical Virtual Reality Therapy. Its primary akta.pro industry code is HLALAAAA, Primary Care & General Medicine Virtual Care. Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals